RXI PHARMACEUTICALS CORP
RXI PHARMACEUTICALS CORP (RXII) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 357 transactions totaling $19.0M, demonstrating a bearish sentiment with -$18.5M in net insider flow. The most recent transaction on Nov 9, 2018 involved a transaction of 18,698 shares valued at $8.0K.
RXII Insider Activity Summary
Who Is Buying RXII Stock?
No significant insider buying has been recorded for RXII in the recent period.
Who Is Selling RXII Stock?
No significant insider selling has been recorded for RXII in the recent period.
Is RXI PHARMACEUTICALS CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RXII is bearish with an Insider Alignment Score of 1/100 and a net flow of -$18.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
RXII Frequently Asked Questions
Understanding RXII Insider Activity
Insider trading at RXI PHARMACEUTICALS CORP (RXII) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading RXII stock, having executed 357 transactions in the past 90 days. The most active insider is Corp Cytrx (Executive), who has made 7 transactions totaling $17.2M.
Related Tools
Track RXI PHARMACEUTICALS CORP Insider Activity
Get notified when executives and directors at RXII file new Form 4 transactions